The Effect of Exercise on Cognitive Status in Older Adults

September 4, 2022 updated by: Ismail Uysal, Muğla Sıtkı Koçman University

Is Aerobic and Dual-task Training Combination the Most Effective Exercise Combination to Improve the Cognitive Status and Physical Function in Older Adults With Mild Cognitive Decline

The purpose of the study is to demonstrate the effectiveness of the different combinations of exercises on the cognitive status of older adults with cognitive decline.

Study Overview

Detailed Description

This study is planned to examine the effects of combined exercise on cognitive status, lower extremity muscle strength, mobility, physical performance, mood and quality of life in older adults with Mild Cognitive Impairment. Aerobic exercise training and lower limb (extremity) strengthening exercises were applied to the first group, dual-task training and lower limb strengthening exercises were applied to the second group, and aerobic exercise training, dual-task training and lower limb strengthening exercises were applied to the third group.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06500
        • Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Not had a fall in the last six months.
  • Older adults with an mini mental state examination score between18-23.
  • Age ≥ 65years.

Exclusion Criteria:

  • having central nervous system pathology that will affect balance
  • diagnosed with vestibular pathology,
  • having deformities in the waist, hip, and knee joints,
  • having lower extremity amputation,
  • with lower extremity operation history,
  • malignancy affecting the lower extremity,
  • having moderate and severe congenital heart disease, coronary heart disease and cerebrovascular disease,
  • participants who cannot cooperate,
  • participants who use an assistive walking device,
  • participants having vision problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic exercise training combined with lower limb strengthening group (AG)
Aerobic exercise training combined with lower limb strengthening.
The participants performed aerobic exercise training and lower limb strengthening during this intervention.
Experimental: Dual-task training combined with lower limb strengthening group (DG)
Dual-task training combined with lower limb strengthening.
The participants performed dual-task training combined with lower limb strengthening during this intervention.
Experimental: Aerobic exercise training combined with dual-task training and lower limb strengthening group (ADG)
Aerobic exercise training combined with dual-task training and lower limb strengthening.
The participants performed aerobic exercise training combined with dual-task training and lower limb strengthening during this intervention.
Active Comparator: Only lower limb strengthening group (CG)
Only lower limb strengthening.
The participants performed only lower limb strengthening group during this intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini-Mental State Examination
Time Frame: 12 weeks
Cognitive status examination is applied with a simple test called "Mini-Mental State Examination".
12 weeks
Commander Power Track 2 Manual Tester
Time Frame: 12 weeks
Muscle strength strength is carried out with "Commander Power Track 2 Manual Tester".
12 weeks
Timed Up and Go Test
Time Frame: 12 weeks
Functional mobility is evaluated by Timed Up and Go Test.
12 weeks
Single Leg Stance Test
Time Frame: 12 weeks
Static balance is evaluated by Single Leg Stance Test
12 weeks
Activities-specific Balance Confidence Scale
Time Frame: 12 weeks
Balance Confidence is evaluated by Activities-specific Balance Confidence Scale.
12 weeks
Six-Minute Walk Test
Time Frame: 12 weeks
Exercise capacity is evaluated by Six-Minute Walk Test.
12 weeks
Short Physical Performance Battery
Time Frame: 12 weeks
Physical performance is evaluated by Short Physical Performance Battery.
12 weeks
Hamilton Depression Rating Scale
Time Frame: 12 weeks
Emotional status is evaluated by Hamilton Depression Rating Scale
12 weeks
World Health Organization Quality of Life-Old module
Time Frame: 12 weeks
Quality of life is evaluated by World Health Organization Quality of Life-Old module
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: İsmail Uysal, PhD, Muğla Sıtkı Koçman University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2019

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

February 1, 2020

Study Registration Dates

First Submitted

September 4, 2022

First Submitted That Met QC Criteria

September 4, 2022

First Posted (Actual)

September 8, 2022

Study Record Updates

Last Update Posted (Actual)

September 8, 2022

Last Update Submitted That Met QC Criteria

September 4, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Gazi University (Other Identifier: Research Projects Coordination Unit)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe